Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Nifty June futures trade at premium
HDFC Bank (India) Infosys and Tata Consultancy Services were the top traded contract.
Nifty June futures trade at premium
HDFC Bank (India), Reliance Industries and Infosys were the top traded contract.
Nifty June futures trade at premium
Infosys, TCS and HDFC Bank were top traded contracts
Bharat Forge, GE Vernova among 10 midcap stocks that hit 52-week highs & rallied up to 20% in a month
The Sensex rose 254 points to close at 77,409 on Thursday, lifting broader markets. Ten BSE 150 MidCap stocks touched fresh 52-week highs, signalling strong investor confidence. GE Vernova T&D India led gains, while banking, infrastructure and industrial stocks also advanced.
Stocks in news: IFCI, Tata Motors, General Insurance Corp, Corona Remedies, HFCL
Markets extended their winning streak for the fourth consecutive session, driven by favorable global cues and sustained sector-wide buying. The Nifty reclaimed the 24,000 mark, approaching the 100-day EMA near 24,150. Stocks like IFCI, Tata Motors, and HFCL are in focus due to significant news developments, including IPO filings, turnaround projections, and major order wins.
Nifty June futures trade at premium
Tata Motors PV, HDFC Bank and Infy were top traded contracts
Nifty June futures trade at a premium
HDFC Bank, Reliance Inds and L&T were top traded contracts
Nifty June futures trade at a premium
HDFC Bank, ICICI Bank and Reliance Industries were the top traded contracts.
Nifty June futures trade at a premium
HDFC Bank, Reliance Industries and ICICI Bank were the top traded contracts.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.

Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.